期刊文献+

抗菌药物耐药性的演变动向 被引量:3

Development and trend of drug tolerance of antibiotics
下载PDF
导出
摘要 虽然近几十年来新的抗菌药物不断问世,但医院或社区获得的病原菌对各种抗菌药物的敏感性有不同程度的改变.四年来拉丁美洲泌尿系感染的病原菌中,耐碳青霉烯铜绿假单胞菌、耐环丙沙星大肠埃希菌及产ESBL克雷伯菌已成为严重问题[1].
作者 谢景超
出处 《中南药学》 CAS 2003年第1期46-49,共4页 Central South Pharmacy
  • 相关文献

参考文献32

  • 1[1]Gales AC,Sader HS,Jones RN.Urinary tract infection trends in Latin America n hospitals:report from the SENTRY antimicrobial surveillance program(1997~200 0)[J].Diagn Microbiol infect Dis,2002,44(3):289.
  • 2[2]Gums JG.Assessing the impact of antimicrobial resistance [J].Am J Hea lth-Syst pharm,2002,59(3):4.
  • 3[3]Landman D,Quale JM,Mayorga D,et al.Citywide clonal outbreak of multiresistant acinetobacter baumannii and pseudomonas aeruginosa in Brooklyn ,NY.The Preantibiotic Era Has Returned [J].Arch Inter Med,20 02,162:1515.
  • 4[4]Roland RK,Mendes RE,Silbert S,et al.In vitro antimicrobial a ctivity of pipera cillin/tazobactam in comparison with other broad-spectrum beta-lactams [J]. Braz J Infect Dis,2000,4(5):226.
  • 5[5]Johnson DM,Biedenbach DJ,Jones RN.Potency and actimicrobial spectrum upda te for Piperacillin/tazobactam(2000):emphasis on its activity against resistan t organism populations and generally untested species causing community-acquire d respiratory tract infections[J].Diagn Microbiol Infect Dis, 2002,43(1):49.
  • 6[6]Young M,Plosker GL.Piperacillin/Tazobactam in moderate to severe bacteria l infections[J].Dis Manage Health Outcomes,2002,10(3):195.
  • 7[7]Allegranzi B,Luzzati R,Luzzani A,et al.Impact of antibiotic c hanges in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections [J].J Hosp Infect,2002,52(2):136 .
  • 8[8]Lamb HM,Ormrod D,Scott LJ,et al.Ceftriaxone-an update of it s use in the mana gement of community acquired and nosocomial infections [J].Drugs,2002,62(7):1041.
  • 9[9]Krontal S,Leibovitz E,Greenwald-Maimon M,et al.Klebsiella ba cteremia in Chil dren in southern Israel(1988~1997)[J].Infection,2002,30 (3):125.
  • 10[10]Chiappini E,Galli L,Pecile P.et al.Results of a 5-year prospe ctive surveillan ce study of antibiotic resistance among salmonella enterica isolates and ceftria xone therapy among children hospitalized for acute diarrhea [J].Clin T her,2002,24(10):1585.

二级参考文献3

  • 1李家泰,中华内科杂志,1995年,34卷,680页
  • 2张婴元,中华内科杂志,1995年,34卷,676页
  • 3王学文,实用内科杂志,1989年,12卷,666页

共引文献12

同被引文献20

  • 1岳向荣,董卫,赵海军.128株鲍曼不动杆菌的耐药性分析[J].检验医学与临床,2006,3(2):80-81. 被引量:7
  • 2马越,金少鸿.抗生素的合理使用与遏制细菌耐药性的发展[J].中华检验医学杂志,2004,27(8):481-482. 被引量:22
  • 3高晨,段蕴铀,赵志刚.全国14家医院抗菌药物合理用药调研[J].中国新药杂志,2004,13(12):1178-1179. 被引量:1
  • 4李荔,杨静.我院456例药物不良反应分析[J].中国新药杂志,2005,14(5):642-644. 被引量:36
  • 5谢景超.控制细菌耐药的措施[J].中南药学,2006,4(5):392-393. 被引量:8
  • 6Domenech-Sanchez A , Pascual A , Suarez AI, et al. Activity of nine antimicrobiala gents against clinical isolates of klebsiella paeumoniae producing extended-spectrum lactamases and deficient or not in porins [J]. J Antimicrob Chemother, 2000, 46 (6): 858-859.
  • 7Hall MAL, Paauw A, Box ATA, et al. Presence of integron-associated resistance in the community is widespread and contributes to multidrug resistance in the hospital [J].J Clin Microbiol, 2002, 40 (8): 3038-3040.
  • 8National Committee for Clinical Laboratory Standards. Perfor manre standards for antimicrobial susceptibility testing. 9th in formationalsupplemented [S]. W zyne, PA : National Corn mittee for Clinical Laboratory Standards, 1999: 32-36.
  • 9World Health Organization. WHO Global strategy for containment of antimierobial resistance [S]. WHO/CDS/CSR/DRS/ 2001 : 2.
  • 10[12]Weiss K,Restieri C,Decarolis E,et al.Comparative activity of new quinolones against 326 clinical isolates of S tenot rophomonas mal tophi lia[J].J Antimicrob Chemother,2000,45 (3):363-365.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部